A Clinical trial study the effect of Rasa chendhuram in patients with vitiligo

AN OPEN COMPARATIVE CLINICAL EVALUATION ON VENPULLI (VITILIGO) WITH SIDDHA TRIAL DRUGS "RASA CHENDHURAM" (INTERNAL) AND PALAGARAI KUZHAMBU (EXTERNAL)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/07/008969

Enrollment

Registered

2017-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- VENPULLI(VITILIGO)

Interventions

Intervention1: Rasa chendhuram(int) palagarai kuzhambu (ext): 20 Patient treated with Rasa chendhuram(internal) 65mg with honey twice a day Palagarai kuzhambu(external) application for 48days Interven

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hypo-pigmented patches with hyper pigmented border without any structural changes in any part of the body. 2.Patient willing to sign consent form.

Exclusion criteria

Exclusion criteria: Albinism Leprosy STD 1.HIV 2.Burns 3.Pregnant women and Lactating mothers 4.Cardiac diseases 5.History of long term use of steroids.

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drugs will be assessed by repigmentation and also by reduction in the size of â??VASIâ?? Score (Vitiligo area scoring index) Timepoint: 12months	—

Secondary

Measure	Time frame
The safety of the trial drugs is measuredTimepoint: 12months	—

Countries

India

Contacts

Public ContactDr R Kalaimani

govt siddha medical college

spmhibiscus@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026